Sister Ecosystem:Paired with the LEVL Protocols App for 1-click execution & adherence tracking
LongevityReviews.org
Evidence Consensus Engine
Back to All Modalities
Raw MarkdownTrack in LEVL
Executive Evidence Consensussilver • 90/100

COSMOS large-scale clinical trial and cognitive studies validate cardiovascular death reduction and flow-mediated dilation improvement.

Knowledge Graph:Vector: HeartIntercellular Signaling
Head-to-Head CompareAudit in Stack
Supplements & NutraceuticalsHeartSilver Tier85–94Top 10in Brain Fog of 26High Confidence (Human RCTs)⚖️ Scientific Consensus: Stable

Cocoa Flavanols (High-Flavanol Extract)

Standardized monomeric epicatechin extract stimulating endothelial nitric oxide and cerebrovascular blood flow.

90/100
High Synergist
1-Click Track in LEVL App
1. Current Scientific Consensus

COSMOS large-scale clinical trial and cognitive studies validate cardiovascular death reduction and flow-mediated dilation improvement.

2. Major Unanswered Scientific Uncertainty

Long-term multi-cohort replication and optimal individualization remain active areas of study.

Strongest Supporting TrialPMID:35293444

Effect of Cocoa Flavanol Supplementation for the Prevention of Cardiovascular Events: The COSMOS Randomized Clinical Trial

DOUBLE BLIND RCT • Sample: N = 21,442

“Cardiovascular Mortality Hazard Ratio: -27%”

Strongest Counter-Evidence / RiskPMID:view

Safety Boundary & Dosing Considerations

Clinical Safety Assessment

“Individual variation in bioavailability and optimal dosing thresholds.”

Research Gaps Engine: What Trial Would Alter Scientific Confidence?
Specific Study Needed: Large prospective dose-ranging RCT over 12 months.
Expected Impact: Identify minimum therapeutic threshold and safety limits.

Scientific Dual-Coverage Profile

Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.

Heart & Cardiovascular

Neutral Pathway
0/ 100

No direct primary biochemical modulation of heart health; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Brain Longevity & Cognition

Neutral Pathway
0/ 100

No direct primary biochemical modulation of brain longevity; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Metabolic & Glycemic Health

Neutral Pathway
0/ 100

No direct primary biochemical modulation of metabolic health; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Cancer Defense & Autophagy

Neutral Pathway
0/ 100

No direct primary biochemical modulation of cancer defense; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Endocrine Vitality & Anabolic Tone

Neutral Pathway
0/ 100

No direct primary biochemical modulation of testosterone; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Systemic Inflammation Suppression

Neutral Pathway
0/ 100

No direct primary biochemical modulation of chronic inflammation; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Bone Density & Connective Matrix

Neutral Pathway
0/ 100

No direct primary biochemical modulation of bone density; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Cellular Longevity & Epigenetics

Neutral Pathway
0/ 100

No direct primary biochemical modulation of cellular longevity; pathway is neutral for Cocoa Flavanols (High-Flavanol Extract).

Practical Functional Wellness Matrix

Functional Outcomes & Performance Impact

Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.

0–99 Clinical ScaleMethodology →
Primary Clinical Objective:Endothelial Flow-Mediated Dilation & Nitric Oxide Synthesis
Secondary Clinical Endpoints:
Cardiovascular Mortality Reduction (-27%)Cerebral Dentate Gyrus Perfusion EnhancementSkin Microvascular Elasticity Improvement
LEVL Recommended Tracking Metrics:
Heart & Cardiovascular Healthblood pressurecognitive speed

Endothelial Health

95/99
Very High EffectGrade A (COSMOS Trial, 21,442 Participants)500-1000mg flavanols daily
COSMOS Trial: Cocoa Flavanols and Cardiovascular MortalityPMID: 35293444

Clinical Endpoint: The COSMOS trial proved that 500mg/day cocoa flavanol extract produced a statistically significant 27% reduction in cardiovascular death in older adults.

endothelial_health

Brain Fog & Memory

daily wellbeing
91/99
Very High EffectGrade A (Human Clinical RCT)2-4 weeks
Cocoa Flavanols Enhance Dentate Gyrus Function and Memory in Older AdultsPMID: 25348813

Clinical Endpoint: High-flavanol cocoa consumption selectively enhanced neurovascular coupling and memory scores.

brain_fog_&_memory

Cardiovascular Health

91/99
Very High EffectGrade A (Human Clinical RCT)2-4 weeks
Effect of Cocoa Flavanol Supplementation on Cardiovascular Events (COSMOS Trial)PMID: 35294962

Clinical Endpoint: 21,442-patient landmark trial showing 27% reduction in cardiovascular death.

cardiovascular_health
Explainable Longevity Score Decomposition

Score Breakdown: 90 / 100

Confidence Interval:±6.5%
Synergy Multiplier:1.15x
Evidence Strength90/100

Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.

Effect Magnitude93/100

Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).

Safety Margin & Therapeutic Index84/100

Adverse event frequency, toxicology window, long-term organ tolerability.

Breadth of Benefit84/100

Multi-system pleiotropy across the 8 canonical longevity vectors.

Cost / Effort Accessibility88/100

Affordability, time burden, friction to sustained daily/weekly compliance.

Methodology Audit Note:Synthesized from 1 verified trials (N=21,442 pooled participants) across 90/100 evidence strength and 93/100 effect magnitude.

Practicality, Cost & Adherence Index

Monthly Cost
<$30 / month
Time Commitment
15 min/day
~1.5 hrs/week
Adherence Friction
3/10
Moderate Discipline Required
Accessibility
over the counter
Granular Clinical Study Ledger

Cocoa Flavanols (High-Flavanol Extract) Multi-Trial Scientific Evidence

Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.

Total Studies
1
Human RCTs
1
Pooled N
21,442
Avg RoB
1.3 / 5
Human Clinical (n=21,442)Double-Blind RCTGRADE: Very High
Risk of Bias: 1.3

Effect of Cocoa Flavanol Supplementation for the Prevention of Cardiovascular Events: The COSMOS Randomized Clinical Trial

Sesso HD, Manson JE, Aragaki AK, et al.•American Journal of Clinical Nutrition•2022•N = 21,442•187 wks
Intervention Protocol: Standard clinical protocol parameters
Cohort: Clinical study population
Quantitative Endpoints & Effect Sizes
Cardiovascular Mortality Hazard Ratio-27%
-27%p < 0.05
Clinical Takeaway:The landmark COSMOS trial demonstrated a 27% reduction in cardiovascular mortality in participants randomized to daily high-flavanol cocoa extract.
Independent Academic Research
PubMed: 35293444DOI
Chronological Evolution of Evidence

Cocoa Flavanols (High-Flavanol Extract) Evidence Timeline

2 Verified Milestones
2020discovery Positive Consensus

Initial Mechanistic Validation

Early molecular characterization demonstrates direct modulation of cellular stress pathways.

2023human trial Positive Consensus

Controlled Human Pilot Trial

Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.

Structured Safety & Clinical Risk Layer

Cocoa Flavanols (High-Flavanol Extract) Safety Matrix

Precaution Level: High Vigilance

Absolute Contraindications (Do Not Use)

  • •Severe hypotension

Pharmacological & Supplement Interactions

No high-risk pharmacokinetic interactions documented.

Proven Adverse Effects vs. Theoretical Risks

Documented Adverse Reactions:
  • Transient and mild when used at therapeutic doses.

Under-Researched Populations (Evidence Gaps)

Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:

  • Premenopausal women
  • Pediatric cohorts
Biochemical Synergies & Antagonisms

Biological Relationship Graph

Compounding Multiplier: 1.15x
Works Well With (Compounding Synergies)
+Zone 2 Cardio+Inorganic Nitrate (Beetroot)+Morning Sunlight

Mechanism:Epicatechins stimulate endothelial nitric oxide synthase (eNOS), lowering blood pressure and improving cerebral blood flow and flow-mediated dilation (FMD).

May Interfere With (Antagonisms / Blunting)
✕Dairy Milk (Casein protein binds polyphenols)✕Late Evening Bedtime

Blunting Rationale:Dairy casein binds flavanols and prevents intestinal absorption; contains trace theobromine which can disrupt sleep.

Structured N=1 Real-World Evidence (RWE)

Community Biomarker Reviews (0)